BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Prognosis
11 results:

  • 1. [Clinical Significance of Genetic and Molecular Changes in Primary Myeloid Sarcoma].
    Jiang YJ; Zhang CF; Wang HX; Zhao L; Zhang FF; Han XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):27-32. PubMed ID: 38387895
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathologic features and outcome of head and neck mucosal spindle cell squamous cell carcinoma.
    Prieto-Granada CN; Xu B; Alzumaili B; Al Rasheed MRH; Eskander A; Enepekides D; Patel SG; Stevens TM; Dogan S; Ghossein R; Katabi N
    Virchows Arch; 2021 Oct; 479(4):729-739. PubMed ID: 33982148
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and pml deficiency.
    Han M; Napier CE; Frölich S; Teber E; Wong T; Noble JR; Choi EHY; Everett RD; Cesare AJ; Reddel RR
    J Cell Sci; 2019 Mar; 132(5):. PubMed ID: 30745338
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Acute appendicitis secondary to acute promyelocytic leukemia.
    Rodriguez EA; Lopez MA; Valluri K; Wang D; Fischer A; Perdomo T
    Am J Case Rep; 2015 Feb; 16():73-6. PubMed ID: 25666852
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
    Heaphy CM; Subhawong AP; Hong SM; Goggins MG; Montgomery EA; Gabrielson E; Netto GJ; Epstein JI; Lotan TL; Westra WH; Shih IeM; Iacobuzio-Donahue CA; Maitra A; Li QK; Eberhart CG; Taube JM; Rakheja D; Kurman RJ; Wu TC; Roden RB; Argani P; De Marzo AM; Terracciano L; Torbenson M; Meeker AK
    Am J Pathol; 2011 Oct; 179(4):1608-15. PubMed ID: 21888887
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. pml expression in soft tissue sarcoma: prognostic and predictive value in alkylating agents/antracycline-based first line therapy.
    Vincenzi B; Santini D; Schiavon G; Frezza AM; Silletta M; Crucitti P; Casali P; Dei Tos AP; Rossi S; Rizzo S; Badalamenti G; Tomasino RM; Russo A; Butrynski JE; Tonini G
    J Cell Physiol; 2012 Apr; 227(4):1657-62. PubMed ID: 21678421
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression.
    Subhawong AP; Heaphy CM; Argani P; Konishi Y; Kouprina N; Nassar H; Vang R; Meeker AK
    Mod Pathol; 2009 Nov; 22(11):1423-31. PubMed ID: 19734843
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Immunohistochemical expression of promyelocytic leukemia body in soft tissue sarcomas.
    Matsuo T; Sugita T; Shimose S; Kubo T; Ishikawa M; Yasunaga Y; Ochi M
    J Exp Clin Cancer Res; 2008 Nov; 27(1):73. PubMed ID: 19025608
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Chromatin structural elements and chromosomal translocations in leukemia.
    Zhang Y; Rowley JD
    DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Biochemical bone resorption markers in children with osteosarcoma].
    Ambroszkiewicz J; Gajewska J; Laskowska-Klita T; Woźniak W
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):225-33. PubMed ID: 15738598
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Long-term follow up of pure myxoid liposarcomas with special reference to local recurrence and progression to round cell lesions.
    Fukuda T; Oshiro Y; Yamamoto I; Tsuneyoshi M
    Pathol Int; 1999 Aug; 49(8):710-5. PubMed ID: 10504538
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.